GPS, which can predict the postoperative outcomes of various cancers [7–9], is a combination of serum C-reactive protein (CRP) and albumin levels, which are biomarkers of systemic inflammatory response and nutritional status, respectively [10]. The gene discussed is CRP; the disease is cancer.